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ABSTRACT 
Objective: The present study was carried out to investigate the role of curcumin in osteoarthritis when it is used as an adjuvant to diclofenac 
sodium.  
Methods: Osteoarthritis (OA) was induced by administering nalidixic acid 400 mg/kg. Animals (Female rats) were divided into 5 groups each 
containing 6 animals. Group I was considered as control, group II in which the animals were induced with osteoarthritis with nalidixic acid and were 
given no treatment. Group III in which osteoarthritis induced animals were treated with diclofenac sodium by the oral route. Group IV osteoarthritis 
induced animals were treated with the combination of diclofenac sodium and curcumin and group V animals were pre-treated with curcumin and 
then induced with osteoarthritis. Parameters like ulcer area, ulcer index, free acidity, total acidity, the volume of gastric juice were estimated. 
Histopathological studies were also carried out.  
Results: The data of our study shows that nalidixic acid has not shown much effect on the gastric parameters in group II animals. The ulcer index, 
free acidity, total acidity and gastric juice volume were increased significantly (p<0.001) in group III and decreased in group IV animals (p<0.05) 
when compared to group I control animals. Group V animals pretreated with curcumin have shown fewer incidences of gastric ulcers and other 
ulcerative parameters non significantly. Histopathology also suggests a low incidence of ulcers in group IV and group V.  
Conclusion: It demonstrates that curcumin when used along with the conventional NSAIDs as an adjuvant therapy, has a role in treating 
osteoarthritis effectively. 
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Osteoarthritis (OA) is a pro-inflammatory degenerative disorder 
affecting millions of individuals in whole over the world [1]. It is the 
most common type of arthritis. Soreness and stiffness in joints, 
Heberden nodes [2] and pain are the common symptoms 
experienced in Osteoarthritis. Alleviating pain is the treatment goal 
in osteoarthritis treatment. Nonsteroidal anti-inflammatory drugs 
(NSAIDs) like diclofenac sodium, naproxen, indomethacin, and 
ibuprofen are conventionally used to reduce the pain.  
Although these drugs help in reducing the pain they cause many 
adverse effects of which gastric ulceration is important which is 
one of the reasons for the increased mortality and morbidity. 
Curcumin is an active constituent available in the rhizome of 
Curcuma longa (Turmeric) which belongs to the family 
Zingiberaceae. Curcumin is thought to possess anti-inflammatory, 
antioxidant, anti-fungal, antiviral properties. It also suppresses the 
tumor formation and blood vessel formation.  
Quinolone antibiotics are the drugs which act by inhibiting DNA 
gyrase and topoisomerase enzyme in bacteria. In addition to this 
activity, it degenerates articular cartilage due to their affinity 
towards the cartilage and bone. Blisters like lesions are formed 
on the cartilage followed by its degeneration after 24 h of its 
administration. This is evidenced by the appearance of nodules 
[3].  
The present study was aimed to investigate the effect of curcumin 
when used with the standard drug in the treatment of Osteoarthritis 
and also its role in the prevention of gastric ulceration when animals 
are pretreated with it. Parameters like ulcer area, ulcer index, free 
acidity, total acidity, the volume of gastric juice were studied. 
Histopathological study of the stomach was also carried out to 
determine the effect of curcumin. 
MATERIALS AND METHODS 
Animals 
24 female Wistar rats weighing around 180-250 g were used for this 
study. The animals were accommodated in standard conditions of 
ventilation and temperature (25±2° C), humidity (60-70%) and 
light/dark condition (12/12). They were housed in pathogen-free 
conditions.  
The animal procedures were conducted according to CPCSEA 
guidelines. Approval for animal studies was obtained from an animal 
ethical committee of TRR College of pharmacy with ethical clearance 
number: 2/IAEC/TRRCP/2016.  
Chemicals  
Curcumin, nalidixic acid, dimethyl Sulfoxide were purchased from 
Hychem Laboratories, Hyderabad.  
Nalidixic acid was administered at a single dose of 400 mg/Kg 
subcutaneously.  
Diclofenac sodium was administered orally at a dose of 13 mg/Kg 
for 21days. Curcumin was given orally at a dose of 200 mg/Kg for 
21 d. 
Experimental design  
The animals were allowed for stabilization or acclimatization for one 
week. Then they were grouped below 5 groups each containing 6 
animals.
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Table 1: Experimental design and treatment of animals 
S. No. Group Treatment 
1 I Vehicle-treated 
2 II Nalidixic acid  
3 III Nalidixic acid+diclofenac sodium  
4 IV Nalidixic acid+diclofenac sodium+curcumin 
5 V Pretreatment with curcumin+nalidixic acid  
 
Female rats (n=30) were divided into five groups. Group I was 
considered as control. Group II, III and IV animals were induced with 
osteoarthritis with the administration of nalidixic acid (400 mg/kg) 
s. c. Group II was disease control group. Group III animals were 
treated with diclofenac sodium (13 mg/kg) p. o and group IV 
animals were treated with the combination of diclofenac sodium (13 
mg/kg) p. o and curcumin (200 mg/kg) p. o. Group V animals were 
pretreated with curcumin (200 mg/kg) and then were administered 
with nalidixic acid (400 mg/kg) s. c. 
Group I: Control group–Animals treated with vehicle 
Group II: Disease control–Osteoarthritis induced animals with 
nalidixic acid  
Group III: Standard group-Osteoarthritis induced animals treated 
with diclofenac sodium  
Group IV: Test group-Osteoarthritis induced animals treated with 
diclofenac sodium and curcumin.  
Group V: Pretreated group-Animals were pretreated with curcumin 
before the induction of Osteoarthritis.  
Estimation of ulcer index 
After the completion of collection of samples, the animals were sacrificed 
and their intact stomachs were isolated. The stomachs were opened 
through greater curvature and washed slowly under tap water to score 
the ulcer. The score of the ulcers formed was given as below:  
0= normal, 0.5 = Red coloration, 1.0 = Spot ulcers, 1.5 = Hemorrhagic 
streaks, 2.0 = ulcers ≥3≤5, 3.0 = more than 5 ulcers [4]. Mean score 
of the ulcers was expressed as ulcer index. The number of ulcers per 
stomach was recorded and was compared with the control. 
Estimation of volume of gastric juice 
After isolating the stomach, the gastric juice was collected and 
gastric secretion studies were performed. The gastric juice was 
measured using measuring cylinder. After cleaning, the stomachs 
isolated were preserved in 0.1 M phosphate saline buffer (1:4 (w/v), 
pH 7.4) prior to macroscopic examination and homogenization [5]. 
Estimation of free acidity and total acidity 
After collecting the gastric juice, the collected juice was centrifuged 
at 1000 rpm for 10 min. The supernatant formed was separated and 
1 ml of it was collected and was made to 10 ml by adding 9 ml of 
distilled water. The resultant solution was titrated with 0.1 N NaOH. 
Topfer's reagent has used an indicator and was added till canary 
yellow color was observed. The amount or volume of NaOH required 
to get the color was noted and was considered as the value of free 
acidity. 2-3 drops of phenolphthalein were used as an indicator and 
were added to NaOH until the pink color was restored. This value 
corresponds to total acidity [5]. The values obtained were compared 
among test, control and standard groups.  
Acidity = Volume of NaOH × Normality of NaOH × 100 mEq/l  
Statistical analysis 
The data were expressed as mean±S. D values. Results were 
analyzed statistically by One-way ANOVA followed by Dunnett’s Test 
using standard statistical software package of Graph pad prism.7. 
The difference was considered significant if */# p<0.05, **/## 
p<0.001, ***/### p<0.0001, ****/#### p<0.00001. 
*All the groups were compared to the control 
#All the groups were compared to the disease control or the group 
with animals induced with osteoarthritis and are given no 
treatment. 
RESULTS 
Effect of various treatments on the ulcerative parameters in 
osteoarthritis (OA) induced rats: 
  
 
Fig. 1: Effect of various treatments on gastric ulcer formation in osteoarthritis (OA) induced rats. All the data is expressed in mean±SD, 
n=6. Control group animals have shown 0 zero ulcers. The ulcers were prominently increased in group III OA induced animals which were 
treated with diclofenac sodium (p<0.001). There is a significant decrease in the ulcer formation in group IV (p<0.05) OA induced animals 
which were treated with diclofenac sodium and curcumin. Group V animals pre-treated with curcumin have shown fewer incidences of 
ulcers. OA= osteoarthritis 
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Fig. 2: Effect of various treatments on free acidity in osteoarthritis (OA) induced rats. All the data are expressed in mean±SD, n=6. The free 
acidity value has increased significantly in Group III (p<0.001) animals which were treated with diclofenac sodium alone when compared 
to Group I (control animals) and II (OA induced animals without treatment) and it has decreased in group IV OA induced animals treated 
with diclofenac sodium and curcumin and group V animals pre-treated with curcumin when compared to group III. OA= osteoarthritis 
 
 
Fig. 3: Effect of various treatments on total acidity in osteoarthritis (OA) induced rats. All the data are expressed in mean±SD, n=6. Total 
acidity value has increased significantly (p<0.001) in group III OA induced animals treated with diclofenac sodium alone when compared 
to group I control animals and II OA induced animals without treatment whereas it is decreased in group IV OA induced animals treated 
with the combination of diclofenac sodium and curcumin and group V animals which were pretreated with curcumin when compared to 
group III. OA= osteoarthritis 
 
 
Fig. 4: Effect of various treatments on volume of gastric juice in osteoarthritis (OA) induced rats. All the data are expressed in mean±SD, 
n=6. The volume of gastric juice is increased significantly in group III (p<0.001) OA induced animals which were treated and group IV 
(p<0.01) OA induced animals treated with the combination of diclofenac sodium and curcumin whereas it decreased in group IV and 
group V animals which were pretreated with curcumin before inducing OA when compared to group III. OA= osteoarthritis 
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Int J Pharm Pharm Sci, Vol 10, Issue 4, 29-34 
 
32 
Histopathology of stomach  
 
Fig. 5: Group I-From the above fig. it is evident that the stomach of animals belonging to control group show distinct mucosa layer (dots 
representing mucosa) with intact submucosa (arrow mark showing submucosa) and muscularis layer without any necrotic areas. The 
villa is preserved and no signs of ulceration (represented by star mark) were seen. Group II-osteoarthritis induced animals with no 
treatment have shown normal tissue of stomach with intact submucosa (represented by arrow mark) and muscularis without necrosis. 
There was no ulceration. The villi appear to be normal (represented by star mark). Group III-Osteoarthritis induced animals treated with 
diclofenac sodium has shown marked changes in the tissue with severe ulceration exposing submucosa (arrow mark representing 
submucosa) layer with damaged villi (star representing villi). The muscularis layer has shown widespread atrophic gastritis with blood 
vessels showing intimal thickening (red mark). There was a severe mucosal degeneration with ulcerated area. Group IV-Osteoarthritis 
induced animals treated with the combination of diclofenac sodium and curcumin has shown very few ulcers with well-preserved mucosa 
(dots representation), intact submucosa (arrow mark) and distinct muscularis beneath. Villi appear to be normal. Group V-Animals pre-
treated with curcumin and induced with Osteoarthritis has also shown the intact structure of stomach with less damage. The mucosa 
(dots), submucosa (represented by the arrow) and muscularis were distinct. All the cells were found to be normal 
 
DISCUSSION 
Alleviating the pain is the main goal in the treatment of 
osteoarthritis. It is accomplished by using Non-steroidal anti-
inflammatory drugs like diclofenac sodium, naproxen, ibuprofen etc. 
Gastrointestinal irritation and ulcers are the major limitations of the 
usage of these NSAIDs. NSAIDs cause gastric injury both by 
prostaglandin-dependent and prostaglandin-independent 
mechanisms. They cause damage to the stomach mainly by acting as 
an irritant, interfering with the defense and repair mechanism of 
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mucosa and epithelium. Prostaglandins, Nitric oxide synthesis, and 
enteric nervous system are the key regulators which maintain the 
integrity of mucosa. Usage of NSAIDs compromises the mucosal 
blood flow, mucous secretion, and hydrophobic environment. They 
also impair restitution process interfering with the homeostasis. 
Three defense mechanisms are involved in gastric mucosa [6, 7].  
The first defense mechanism consists of a barrier layer which is made 
up of mucosa, bicarbonates, and phospholipids which protects the 
gastric mucosa from noxious agents. The mucosa secreted by the 
epithelial layer and bicarbonate ions together maintain the neutral pH 
when there is an excess of gastric acid secretion making it acidic. The 
second mechanism comprises of epithelial cells. These cells prevent 
the diffusion of H+ions into them because of the tight junctions 
between them. The damaged epithelial cells will be shed forming a 
protective layer. The cells which are below get attached to mucous and 
migrate to damaged area helping in restoring the damaged cells-the 
process is called as restitution. The third mechanism involves high 
vascularity of mucosa which helps in supplying the required amount of 
oxygen and nutrients so that they can release an adequate amount of 
mucous and permeability. All these defense mechanisms are regulated 
and maintained by synthesis of prostaglandins. As NSAIDs are COX 
inhibitors, they reduce the pain by inhibiting the prostaglandin 
synthesis which is the key regulators of the defense mechanisms in the 
mucous membrane. Due to deficiency of prostaglandins during the 
usage of NSAIDs, the mucosal barrier and mucosal integrity are lost 
leading to the gastric injury.  
Prostaglandin independent mechanism is explained by “Trapping 
theory” [8]. As NSAIDs are weak organic acids, they are unionized 
and lipophilic in the gastric environment. As these molecules get 
rapidly absorbed, they get into the gastric mucosal cell membrane 
where the pH is neutral. NSAIDs get the ionized and lipophobic form. 
Due to this nature, they get trapped and accumulate in the cell 
causing gastric injury. NSAIDs inhibit the mitochondrial metabolic 
pathways i. e oxidative phosphorylation to decreases the 
mitochondrial transmembrane potential (MTP) that results in 
releasing of cytochrome C from mitochondria into the cytoplasm [9, 
10]. Cytochrome c is the component which is involved in the 
initiation of apoptosis. It also results in the release of ROS, such as 
superoxides (O2-) and hydrogen peroxide (H2O2) which causes 
activation of caspase 9 and caspase 3, cellular lipid peroxidation 
finally resulting in programmed cell death process called as 
apoptosis. The uncoupling of mitochondria also results in decreased 
ATP concentration which causes leakage of calcium ions leading to a 
loss of cellular osmotic balance and control over intracellular 
functions resulting in increased permeability and subsequent neural 
damage in the intestine. As there is disturbance or alteration in the 
permeability of mucosal layer in the stomach as well as in intestine, 
the cells are uncovered and are exposed to all the contents of the 
lumen-like bile acids, proteolytic enzymes, pancreatic enzymes, 
intestinal bacteria causing neutrophil chemotaxis. Neutrophil 
activation results in inflammation and ulceration. Due to these 
effects caused by NSAIDs, there is an immediate need for an 
alternative therapy or an adjuvant therapy which can combat this 
effect and help in effectively treating the pain in Osteoarthritis or 
any chronic inflammatory disease. Herbal medicine is considered to 
be safest alternative or adjuvant because of their easy availability, 
high safety with no adverse effects. In this study due to its anti-
inflammatory effect, curcumin is taken as an adjuvant therapy.  
Curcumin has considerable and significant gastroprotective and 
antiulcerogenic effects. Its antiulcer activity is due to its inhibition of 
hypersecretion of gastric acid, total peroxides, IL-6, apoptotic 
enhancers and also on pepsin secretion. The phenolic (OH) group in 
the structure of curcumin plays an important role in anticancer 
activity which in turn is because of its antioxidant activity. NSAIDS 
inactivates gastric peroxidase enzyme and causes ROS mediated 
gastric mucosal injury. Curcumin protects peroxide enzymes from 
inactivation, removes H2 O2 from the cells and decreases gastric 
damage [11]. The gastric cellular injury is also enhanced by 
inflammation with the release of several inflammatory cytokines 
and leukocyte adhesions [12]. Curcumin, as it has anti-inflammatory 
activity, inhibits inflammation and gastric ulceration. Curcumin in 
addition specifically acts on COX-2 and Thromboxane A2 (TXA2) 
when compared to COX-1 without affecting the synthesis of 
protective prostaglandins; it also inhibits LOX (lipoxygenase), 
induced nitric oxide synthase (iNOS) enzymes which are also 
important mediators of inflammation. All these activities of 
curcumin serve as an evidence for its anti-ulcer and gastroprotective 
action. Curcumin induces Heme-oxygenase-1(H0-1) enzyme 
expression through the Nrf2/ARE pathway which is a protective 
mechanism against oxidative stress condition which exists in 
osteoarthritis [13]. It also induces the expression of HO-1 by 
decreasing the level of Bach-1which is the repressor factor of H0-1. 
Deficiency of Bach-1 increases the expression of HO-1 thereby 
inducing antioxidant action [14]. Curcumin also inhibits TNF-α 
induced ICAM-1 expression which is responsible for leucocytes 
infiltration promoting inflammation [15]. In addition, curcumin also 
stimulates and activates transcription factors responsible for the 
expression of glutathione, catalase, superoxide dismutase which are 
important antioxidant systems [16, 17]. Therefore, curcumin can 
reduce leukocyte infiltration and can modulate different pathways of 
oxidative stress thereby acting as a potent antioxidant. It also 
decreases expression of thioredoxin-interacting protein (TXNIP) 
which is actually an oxidative stress mediator. It is a potent 
regulator of redox systems [18]. In hypoxia conditions, TXNIP is up-
regulated attributing to oxidative stress. Histopathological studies 
also support the activity of curcumin as a gastroprotective agent. 
CONCLUSION 
Curcumin was found to have gastroprotective and anti ulcerogenic 
activity in this study and therefore it can serve as an adjuvant 
therapy to NSAIDs to alleviate the pain. In addition due to its anti-
inflammatory properties, it can effectively help in treating 
Osteoarthritis thereby improving the quality of life in Osteoarthritis 
patients. As it is an herbal drug, it is safe even in age-old patients in 
whom Osteoarthritis is the major disorder in today's world.  
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